Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Kuzenkova

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 23, 2017
[Pharmacotherapy of attention deficit hyperactivity disorder in children: the results of a multicenter double-blind placebo-controlled study of hopantenic acid]N N Zavadenko, N Yu Suvorinova, I N Vakula, et al.
Voprosy Pitaniia|February 5, 2016
[Evaluation of physical development in children with classical phenylketonuria]T V Bushueva, T E Borovik, K S Ladodo, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 18, 2020
[Changes of the spasticity patterns in children with cerebral palsy GMFCS III at the age of 2 to 12 years]A L Kurenkov, L M Kuzenkova, D A Fisenko, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|December 30, 2015
[Sanfilippo Syndrome]L A Osipova, L M Kuzenkova, L S Namazova-Baranova, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 31, 2015
[Clinical experience of the repeated multilevel injections of the botulinum toxin type A (abobotulinum toxin A) in the spastic forms of cerebral palsy]O A Klochkova, A L Kurenkov, H M Karimova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 14, 2020
[Botulinum toxin type A (Incobotulinum toxin A) in spastic forms of cerebral palsy: a retrospective analysis of clinical experience]A L Kurenkov, L M Kuzenkova, B I Bursagova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 7, 2013
[An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy]A L Kurenkov, L M Kuzenkova, B I Burgasova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 5, 2013
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis]O V Bykova, I A Nankina, A N Platonova, et al.
Molekuliarnaia Biologiia|November 25, 2010
[Analysis of linkage and association of alleles of proinflammatory cytokines genes IL-6, IFNg and TNF with multiple sclerosis using transmission disequilibrium test (TDT)]O Iu Makarycheva, E Iu Tsareva, M A Sudomoina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 11, 2015
[Selection of a dose of the botulinum toxin A in spastic forms of cerebral palsy]A L Kurenkov, O A Klochkova, Kh M Karimova, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 23, 2017
[Pharmacotherapy of attention deficit hyperactivity disorder in children: the results of a multicenter double-blind placebo-controlled study of hopantenic acid]N N Zavadenko, N Yu Suvorinova, I N Vakula, et al.
Voprosy Pitaniia|February 5, 2016
[Evaluation of physical development in children with classical phenylketonuria]T V Bushueva, T E Borovik, K S Ladodo, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 18, 2020
[Changes of the spasticity patterns in children with cerebral palsy GMFCS III at the age of 2 to 12 years]A L Kurenkov, L M Kuzenkova, D A Fisenko, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|December 30, 2015
[Sanfilippo Syndrome]L A Osipova, L M Kuzenkova, L S Namazova-Baranova, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 31, 2015
[Clinical experience of the repeated multilevel injections of the botulinum toxin type A (abobotulinum toxin A) in the spastic forms of cerebral palsy]O A Klochkova, A L Kurenkov, H M Karimova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 14, 2020
[Botulinum toxin type A (Incobotulinum toxin A) in spastic forms of cerebral palsy: a retrospective analysis of clinical experience]A L Kurenkov, L M Kuzenkova, B I Bursagova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 7, 2013
[An electromyographic study on the development of optimal tactics of botulinum toxin type A injections in children with spastic forms of cerebral palsy]A L Kurenkov, L M Kuzenkova, B I Burgasova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 5, 2013
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis]O V Bykova, I A Nankina, A N Platonova, et al.
Molekuliarnaia Biologiia|November 25, 2010
[Analysis of linkage and association of alleles of proinflammatory cytokines genes IL-6, IFNg and TNF with multiple sclerosis using transmission disequilibrium test (TDT)]O Iu Makarycheva, E Iu Tsareva, M A Sudomoina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 11, 2015
[Selection of a dose of the botulinum toxin A in spastic forms of cerebral palsy]A L Kurenkov, O A Klochkova, Kh M Karimova, et al.
Pageof 3